Julie Oniszczuk

NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic Syndrome

A. Boumédiène, Pauline Vachin, Kélhia Sendeyo et al. · Journal of Autoimmunity · 2017 · 95 citations

Medicine, Immunology, Nephrology +13

The spectrum of kidney biopsies in hospitalized patients with COVID-19, acute kidney injury and/or proteinuria

Sophie Ferlicot, Matthieu Jamme, F. Gaillard et al. · Nephrology Dialysis Transplantation · 2021 · 88 citations · Full text

Medicine, Internal Medicine, Nephrology +13

Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults

Julie Oniszczuk, Asma Beldi‐Ferchiou, Étienne Audureau et al. · Nephrology Dialysis Transplantation · 2020 · 36 citations

Medicine, Immunology, Nephrology +14

Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study

Camille Lanaret, Dany Anglicheau, Vincent Audard et al. · American Journal of Transplantation · 2021 · 26 citations

Medicine, Nephrology, Pharmacotherapy +11

Cationic poly(cyclodextrin)/alginate nanocapsules: From design to application as efficient delivery vehicle of 4-hydroxy tamoxifen to podocyte in vitro

Sabrina Belbekhouche, Julie Oniszczuk, André Pawlak et al. · Colloids and Surfaces B Biointerfaces · 2019 · 24 citations · Full text

Pharmacy, Bioengineering, Pharmaceutics +17